Epigenomic Remodeling of Metabolism by Exercise through AP-1
AP-1 对运动代谢的表观基因组重塑
基本信息
- 批准号:9765305
- 负责人:
- 金额:$ 39.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-01 至 2021-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressBinding SitesBloodClinicalClinical TrialsDataDiabetes MellitusDietDiseaseDominant-Negative MutationEconomic BurdenEnhancersEnzymesEpigenetic ProcessEvolutionExerciseExercise PhysiologyGene ExpressionGene Expression ProfilingGene Expression RegulationGenesGenomeGlucoseGlucose ClampGlucose IntoleranceHealthHormonesHumanIn VitroKnock-outKnockout MiceKnowledgeLipidsMalignant NeoplasmsMeasurementMediatingMetabolicMetabolic DiseasesMetabolic syndromeMetabolismMitochondriaMolecular AnalysisMusMuscleMuscle ContractionMuscle FibersNon-Insulin-Dependent Diabetes MellitusNuclearObesityOxidation-ReductionPathway interactionsPharmaceutical PreparationsPhysical ExercisePlayPublic HealthRNAReactive Oxygen SpeciesRoleRunningSignal TransductionSkeletal MuscleSystemTestingWorkbiological adaptation to stressdrug discoveryepigenomeepigenomicsglucose metabolismglucose toleranceglucose uptakehistone modificationin vivoinsightinsulin sensitizing drugsinsulin signalinginsulin toleranceloss of functionmouse modelmutantoverexpressionpandemic diseaseprogramsprotein activationrecruitscreeningtranscription factortranscriptome sequencinguptake
项目摘要
Project Summary/Abstract
We want to address how physical exercise remodels metabolism and ameliorates type 2 diabetes. Exercise is
a first-line treatment for type 2 diabetes, and exerts its beneficial effects not only by burning off energy but also
by causing prolonged metabolic changes through epigenomic regulation of gene expression. Nonbiased
identification of key epigenomic players that mediate exercise-induced gene expression changes has not been
attempted. Using global nuclear-run on (GRO-seq) and enhancer RNA (eRNA) as functional enhancer
markers, we identified activation protein-1 (AP-1) as the dominant transcription factors that drive exercise-
induced enhancers in mouse skeletal muscles after bouts of exercise. Loss-of-function screening identified the
pivotal role of JunD, an AP-1 factor, in muscle contraction-induced stress response and metabolic changes in
fully-differentiated primary myotubes. We will address the in vivo function of JunD/AP-1 in exercise-mediated
metabolic remodeling using conditional knockout and overexpression mouse models. We will also characterize
the upstream signals that activates JunD/AP-1, determine the genuine target genes and epigenomic changes
controlled by JunD/AP-1, and address the conservation of the JunD pathway in human exercise physiology.
Together, this work will provide epigenomic insights into the intermediary metabolism system that is shaped by
intermittent exercise during natural evolution. This will lay intellectual groundwork for drug discovery programs
that aim to maximize the metabolic benefit of physical exercise, especially considering that accumulating
epigenome-modifying drugs are available and show promises in treating cancer and many other diseases in
clinical trials.
项目摘要/摘要
我们想解决体育锻炼如何改造代谢和改善2型糖尿病。运动是
对2型糖尿病的一线治疗
通过通过基因表达的表观基因组调节引起长期的代谢变化。不偏见
鉴定介导运动诱导的基因表达变化的关键表观基因组玩家尚未
尝试。在(GRO-SEQ)和增强子RNA(ERNA)上使用全球核运行作为功能增强器
标记,我们确定活化蛋白-1(AP-1)是驱动运动的主要转录因子 -
运动后诱导小鼠骨骼肌的增强子。功能丧失筛查确定了
JUND(AP-1因子)在肌肉收缩引起的应激反应和代谢变化中的关键作用
完全差异的主要肌管。我们将解决Jund/AP-1在运动介导的体内功能
使用条件基因敲除和过表达鼠标模型进行代谢重塑。我们还将描述
激活Jund/ap-1的上游信号,确定真正的靶基因和表观基因组变化
由Jund/AP-1控制,并解决人类运动生理中Jund途径的保护。
这项工作将共同为中介代谢系统提供表观基因组学的见解
自然进化过程中的间歇性运动。这将为毒品发现计划奠定知识基础
旨在最大化体育锻炼的代谢益处,尤其是考虑到积累
可以使用表观基因组修改药物,并在治疗癌症和许多其他疾病方面有希望
临床试验。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Zheng Sun其他文献
Zheng Sun的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Zheng Sun', 18)}}的其他基金
Inter- and transgenerational effects of paternal arsenic exposure
父亲砷暴露的代际和跨代影响
- 批准号:
10565361 - 财政年份:2023
- 资助金额:
$ 39.63万 - 项目类别:
Revealing the role of blood microbiome in childhood asthma
揭示血液微生物组在儿童哮喘中的作用
- 批准号:
10590805 - 财政年份:2023
- 资助金额:
$ 39.63万 - 项目类别:
Circadian clock gene Rev-erb in memory dysfunction in Alzheimer's disease
生物钟基因 Rev-erb 在阿尔茨海默病记忆功能障碍中的作用
- 批准号:
10095219 - 财政年份:2021
- 资助金额:
$ 39.63万 - 项目类别:
Cardiac Circadian Clock and Dilated Cardiomyopathy
心脏生物钟和扩张型心肌病
- 批准号:
10033596 - 财政年份:2020
- 资助金额:
$ 39.63万 - 项目类别:
Cardiac Circadian Clock and Dilated Cardiomyopathy
心脏生物钟和扩张型心肌病
- 批准号:
10424549 - 财政年份:2020
- 资助金额:
$ 39.63万 - 项目类别:
Cardiac Circadian Clock and Dilated Cardiomyopathy
心脏生物钟和扩张型心肌病
- 批准号:
10625462 - 财政年份:2020
- 资助金额:
$ 39.63万 - 项目类别:
Cardiac Circadian Clock and Dilated Cardiomyopathy
心脏生物钟和扩张型心肌病
- 批准号:
10245139 - 财政年份:2020
- 资助金额:
$ 39.63万 - 项目类别:
De facto Target of Histone Deacetylase Inhibitors
组蛋白脱乙酰酶抑制剂的事实上的靶点
- 批准号:
9296286 - 财政年份:2017
- 资助金额:
$ 39.63万 - 项目类别:
Gender-Specific Effects of Arsenic in Diabetes
砷对糖尿病的性别特异性影响
- 批准号:
10132317 - 财政年份:2017
- 资助金额:
$ 39.63万 - 项目类别:
相似国自然基金
基于三维结构表征学习的RNA结合蛋白绑定位点预测算法研究
- 批准号:62202152
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于三维结构表征学习的RNA结合蛋白绑定位点预测算法研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于深度学习的转录因子绑定位点预测方法研究
- 批准号:62002266
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
海量多源互补蛋白质数据的配体绑定位点预测研究
- 批准号:61902352
- 批准年份:2019
- 资助金额:27.0 万元
- 项目类别:青年科学基金项目
用dsDNA微阵列筛选NF-κB DNA靶点及靶基因
- 批准号:60871014
- 批准年份:2008
- 资助金额:35.0 万元
- 项目类别:面上项目
相似海外基金
A role for cardiomyocyte pannexin 1 in non-ischemic heart failure
心肌细胞pannexin 1在非缺血性心力衰竭中的作用
- 批准号:
10680109 - 财政年份:2023
- 资助金额:
$ 39.63万 - 项目类别:
Targeting Trained Immunity in Trauma-Induced Immune Dysregulation
针对创伤引起的免疫失调中训练有素的免疫力
- 批准号:
10714384 - 财政年份:2023
- 资助金额:
$ 39.63万 - 项目类别:
PBRM1 bromodomain missense mutations in ccRCC vascular signaling
ccRCC 血管信号传导中的 PBRM1 溴结构域错义突变
- 批准号:
10604440 - 财政年份:2023
- 资助金额:
$ 39.63万 - 项目类别:
Landscape and characterization of promoter mutations driving triple-negative breast cancer
驱动三阴性乳腺癌的启动子突变的景观和特征
- 批准号:
10751219 - 财政年份:2023
- 资助金额:
$ 39.63万 - 项目类别: